Interest in the peptide comes primarily from animal research, gut-brain theories, and anecdotal reports
Studies have also not indicated any efficacy of B12 injections in improving cognitive function or mental health
Receptor key: AMY = amylin receptors (fullness signaling)
These findings have positioned FOXO4-DRI as one of the most mechanistically specific senolytic peptides currently available for research purposes, distinguishing it from small-molecule senolytics that operate through broader cellular pathways
It is a triple receptor agonist, meaning it targets three appetite-regulating hormones in the body: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon
Novo Nordisks REDEFINE program, which now includes the newly launched REDEFINE 11 trial, is designed to further optimize CagriSemas positioning across obesity and diabetes care by exploring longer treatment durations and alternative protocol designs